PD-L1-PD-1 interactions limit effector regulatory T cell populations at homeostasis and during infection

Nat Immunol. 2022 May;23(5):743-756. doi: 10.1038/s41590-022-01170-w. Epub 2022 Apr 18.

Abstract

Phenotypic and transcriptional profiling of regulatory T (Treg) cells at homeostasis reveals that T cell receptor activation promotes Treg cells with an effector phenotype (eTreg) characterized by the production of interleukin-10 and expression of the inhibitory receptor PD-1. At homeostasis, blockade of the PD-1 pathway results in enhanced eTreg cell activity, whereas during infection with Toxoplasma gondii, early interferon-γ upregulates myeloid cell expression of PD-L1 associated with reduced Treg cell populations. In infected mice, blockade of PD-L1, complete deletion of PD-1 or lineage-specific deletion of PD-1 in Treg cells prevents loss of eTreg cells. These interventions resulted in a reduced ratio of pathogen-specific effector T cells: eTreg cells and increased levels of interleukin-10 that mitigated the development of immunopathology, but which could compromise parasite control. Thus, eTreg cell expression of PD-1 acts as a sensor to rapidly tune the pool of eTreg cells at homeostasis and during inflammatory processes.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • B7-H1 Antigen* / immunology
  • Homeostasis
  • Interleukin-10 / immunology
  • Mice
  • Programmed Cell Death 1 Receptor* / immunology
  • T-Lymphocytes, Regulatory* / immunology
  • Toxoplasma / immunology
  • Toxoplasmosis, Animal* / immunology

Substances

  • B7-H1 Antigen
  • CD274 protein, human
  • Pdcd1 protein, mouse
  • Programmed Cell Death 1 Receptor
  • Interleukin-10